# TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study

> **NCT04994821** · PHASE2 · COMPLETED · sponsor: **Soterix Medical** · enrollment: 60 (actual)

## Conditions studied

- Cocaine Use Disorder
- Cocaine Dependence

## Interventions

- **DEVICE:** transcranial direct current stimulator (tDCS)
- **BEHAVIORAL:** Cognitive Reappraisal

## Key facts

- **NCT ID:** NCT04994821
- **Lead sponsor:** Soterix Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-28
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04994821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04994821, "TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04994821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
